Company Name	EPS (Basic)	EPS (Diluted)	NAV (per share) (Rs)	P/E (x)	RoNW (%)	P/BV Ratio	Financial statements
Amster Labs Limited	14.96	14.96	22.29		55.67		Restated
Quest Laboratories Limited	9.11	9.11	23.99		35.23		Standalone
Beta Drugs Limited	22.82	22.82	120.67	54.06	18.9		Standalone
Alpa Laboratories Ltd.	8.01	8.01	72.2	10.39	11.04	2.31	Standalone
Zenith Drugs Limited	5.56	5.56	36.28	11.28	15.32		Standalone

Notes:

Considering the nature and turnover of the business of the Company, the peer is not strictly comparable. However, the same have been included for broader comparison.
The figures for Amster Labs Limited (Formerly named M/s Amster Labs a partnership firm converted into Company on 01/01/2024) are based on the restated results for the year ended March 31, 2024, i.e., Combined ratios and figure from April 01, 2023 to December 31, 2023 of Amster labs and January 1, 2024 to March 31, 2024 of Amster Labs Limited.
The figures for the peer group are based on standalone audited results for the respective year ended March 31, 2024.
The Current Market Price (CMP) is the closing price of the respective scrip as of 31 March 2024.

Amster Labs IPO Review by Members

Amster Labs IPO Reviews, analysis and views by popular members. Read Amster Labs Ltd. IPO reviews by retail investors to find recommended ipo to buy.

Amster Labs IPO Review Summary by Members

Review By	Apply	May Apply	Neutral	Avoid
Count	0	0	0	0
%	0.00	0.00	0.00	0.00

Member	Review
No recommendation found. Be the first to post the recommendation.

Note:

The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
We reserve the right to remove any objectionable post without providing a reason.

Useful Articles